Quest Diagnostics Inc. buy Citigroup Inc.
Start price
10.07.24
/
50%
€129.80
Target price
10.07.25
€152.36
Performance (%)
12.33%
End price
11.07.25
€145.80
Summary
This prediction ended on 11.07.25 with a price of €145.80. The prediction had a final performance of 12.33%. Dividends of €1.41 are taken into consideration when calculating the performance. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Quest Diagnostics Inc. | 8.879% | 8.879% | 38.563% |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Quest Diagnostics Inc. diskutieren
Quest Diagnostics Incorporated (NYSE: DGX) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $165.00 price target on the stock, up previously from $145.00.
Ratings data for DGX provided by MarketBeat
In the thread Trading Quest Diagnostics Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Citigroup_Inc_ for Quest Diagnostics Inc.
Quest Diagnostics Inc.
Start price
Target price
Perf. (%)
€146.25
23.10.24
23.10.24
€171.55
23.10.25
23.10.25
7.66%
24.10.25
24.10.25
